607 related articles for article (PubMed ID: 53242)
21. Immunoglobulin production by human peripheral lymphocytes induced by anti-C3 receptor antibodies.
Daha MR; Bloem AC; Ballieux RE
J Immunol; 1984 Mar; 132(3):1197-1201. PubMed ID: 6229578
[TBL] [Abstract][Full Text] [Related]
22. Correlation between effector lymphocytes in natural and antibody-mediated cytotoxicity.
Benczur M; Györffy G; Garam T; Varga M; Medgyesi G; Sándor M; Petranyi GG
Immunobiology; 1979 Sep; 156(3):320-9. PubMed ID: 540970
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the antibody-dependent cytotoxic capabilities of individual human monocytes. Role of Fc gamma RI and Fc gamma RII and the effects of cytokines at the single cell level.
Connor RI; Shen L; Fanger MW
J Immunol; 1990 Sep; 145(5):1483-9. PubMed ID: 1696598
[TBL] [Abstract][Full Text] [Related]
24. ADCC against human erythrocyte target cells: role of the anti-target cell antibodies in determining lymphocyte killer activity.
Nelson DL; Poplack DG; Holiman BJ; Henkart PA
Clin Exp Immunol; 1979 Mar; 35(3):447-53. PubMed ID: 455783
[TBL] [Abstract][Full Text] [Related]
25. Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies.
Ortaldo JR; Woodhouse C; Morgan AC; Herberman RB; Cheresh DA; Reisfeld R
J Immunol; 1987 May; 138(10):3566-72. PubMed ID: 2437198
[TBL] [Abstract][Full Text] [Related]
26. Human lymphocyte cytotoxicity against mumps virus-infected target cells. Requirement for non-T cells.
Härfast B; Andersson T; Perlmann P
J Immunol; 1975 Jun; 114(6):1820-3. PubMed ID: 1168673
[TBL] [Abstract][Full Text] [Related]
27. Cell-mediated cytotoxicity. Characterization of the effector cells.
De Bracco MM; Isturiz MA; Manni JA
Immunology; 1976 Mar; 30(3):325-33. PubMed ID: 1254320
[TBL] [Abstract][Full Text] [Related]
28. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
Bonavida B; Lebow LT; Bradley TP
J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
[TBL] [Abstract][Full Text] [Related]
29. Antibody-dependent cytolytically active human leukocytes: an analysis of inactivation following in vitro interaction with antibody-coated target cells.
Ziegler HK; Henney CS
J Immunol; 1975 Dec; 115(6):1500-4. PubMed ID: 1184963
[TBL] [Abstract][Full Text] [Related]
30. In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis.
Vierling JM; Nelson DL; Strober W; Bundy DM; Jones EA
J Clin Invest; 1977 Nov; 60(5):1116-28. PubMed ID: 332716
[TBL] [Abstract][Full Text] [Related]
31. The antibody-independent cytotoxic activity of normal circulating human leucocytes. II. Failure to demonstrate effector cell-target cell interaction and target cell specificity of the circulating cytotoxic-enhancing factor.
Richter M; Banerjee D; Sklar S
Immunology; 1981 Sep; 44(1):109-18. PubMed ID: 6944271
[TBL] [Abstract][Full Text] [Related]
32. Characterization and utilization of a monoclonal antibody inhibiting porcine natural killer cell activity for isolation of natural killer and killer cells.
Dato ME; Kim YB
J Immunol; 1990 Jun; 144(11):4452-62. PubMed ID: 1971298
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of antibody-dependent cellular cytotoxicity by autologous lymph node cells.
Pollack SB; Herrick MV
J Immunol; 1977 Dec; 119(6):2172-8. PubMed ID: 303260
[TBL] [Abstract][Full Text] [Related]
34. B lymphocytes lacking surface IG in patients with immune deficiency: initiation of IG synthesis in culture in cells of a patient with thymoma.
Siegal FP; Wernet P; Dickler HB; Fu SM; Kunkel HG
Birth Defects Orig Artic Ser; 1975; 11(1):40-4. PubMed ID: 50098
[TBL] [Abstract][Full Text] [Related]
35. Antibody-dependent cellular cytotoxicity against HIV-coated target cells by peripheral blood monocytes from HIV seropositive asymptomatic patients.
Jewett A; Giorgi JV; Bonavida B
J Immunol; 1990 Dec; 145(12):4065-71. PubMed ID: 2258607
[TBL] [Abstract][Full Text] [Related]
36. Antibody-dependent cellular cytotoxicity mediated by subpopulations of human T lymphocytes: killing of human erythrocytes and autologous lymphoid cells.
Katz P; Fauci AS
Immunology; 1980 Mar; 39(3):407-16. PubMed ID: 6969215
[TBL] [Abstract][Full Text] [Related]
37. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.
Lamon EW; Whitten HD; Skurzak HM; Andersson B; Lidin B
J Immunol; 1975 Nov; 115(5):1288-94. PubMed ID: 1080777
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
Neville ME; Hiserodt JC
J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
[TBL] [Abstract][Full Text] [Related]
39. Antibody-dependent cell-mediated cytotoxicity by human lymphocytes: a regulatory role for the sheep red blood cell receptor.
Fuson EW; Cole AJ; Hubbard RA
J Clin Lab Immunol; 1985 Aug; 17(4):183-9. PubMed ID: 2999410
[TBL] [Abstract][Full Text] [Related]
40. Mouse skin graft prolongation with donor strain bone marrow and anti-lymphocyte serum: surface markers of the active bone marrow cells.
De Fazio S; Hartner WC; Monaco AP; Gozzo JJ
J Immunol; 1985 Nov; 135(5):3034-8. PubMed ID: 2864375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
